Company / Current Assets
TriSalus Life Sciences, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$32.2M
FY2025
5-year range
$20.9M / $32.2M
FY2023-FY2025
Trend
+54.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $21M to $32M over the past 2 years.
Based on SEC 10-K filings.
$32M in FY2025.
Improved from $21M to $32M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets increased 54.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.11 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.2M | +54.6% |
| FY2024 | $20.9M | +0.0% |
| FY2023 | $20.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026